Orthosteric and allosteric action of the C5a receptor antagonists.

Published on May 30, 2018in Nature Structural & Molecular Biology12.109
· DOI :10.2210/pdb6c1q/pdb
H. Liu1
Estimated H-index: 1
(University of Pittsburgh),
H.R. Kim1
Estimated H-index: 1
(SKKU: Sungkyunkwan University)
+ 5 AuthorsCheng Zhang13
Estimated H-index: 13
(University of Pittsburgh)
The C5a receptor (C5aR) is a G-protein-coupled receptor (GPCR) that can induce strong inflammatory response to the anaphylatoxin C5a. Targeting C5aR has emerged as a novel anti-inflammatory therapeutic method. However, developing potent C5aR antagonists as drugs has proven difficult. Here, we report two crystal structures of human C5aR in ternary complexes with the peptide antagonist PMX53 and a non-peptide antagonist, either avacopan or NDT9513727. The structures, together with other biophysical, computational docking and cell-based signaling data, reveal the orthosteric action of PMX53 and its effect of stabilizing the C5aR structure, as well as the allosteric action of chemically diverse non-peptide C5aR antagonists with different binding poses. Structural comparison analysis suggests the presence of similar allosteric sites in other GPCRs. We also discuss critical structural features of C5aR in activation, including a novel conformation of helix 8. On the basis of our results, we suggest novel strategies for developing C5aR-targeting drugs.
  • References (69)
  • Citations (13)
📖 Papers frequently viewed together
31 Citations
5 Citations
127 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Nathan RobertsonH-Index: 7
#2Mathieu RappasH-Index: 5
Last. Fiona H. MarshallH-Index: 46
view all 10 authors...
The crystal structure of the complement receptor C5aR1 bound to a small-molecule antagonist provides insights into this receptor class and how they could be better targeted therapeutically.
23 CitationsSource
#1Christopher J. Williams (Duke University)H-Index: 5
#2Jeffrey J. Headd (Duke University)H-Index: 15
Last. David C. Richardson (Duke University)H-Index: 57
view all 18 authors...
This paper describes the current update on macromolecular model validation services that are provided at the MolProbity website, emphasizing changes and additions since the previous review in 2010. There have been many infrastructure improvements, including rewrite of previous Java utilities to now use existing or newly written Python utilities in the open-source CCTBX portion of the Phenix software system. This improves long-term maintainability and enhances the thorough integration of MolProbi...
130 CitationsSource
#1David JayneH-Index: 80
#2Annette Bruchfeld (Karolinska University Hospital)H-Index: 28
Last. Pirow BekkerH-Index: 14
view all 15 authors...
Alternative C activation is involved in the pathogenesis of ANCA-associated vasculitis. However, glucocorticoids used as treatment contribute to the morbidity and mortality of vasculitis. We determined whether avacopan (CCX168), an orally administered, selective C5a receptor inhibitor, could replace oral glucocorticoids without compromising efficacy. In this randomized, placebo-controlled trial, adults with newly diagnosed or relapsing vasculitis received placebo plus prednisone starting at 60 m...
108 CitationsSource
#1X. Edward Zhou (CAS: Chinese Academy of Sciences)H-Index: 22
#2Yuanzheng He (Van Andel Institute)H-Index: 15
Last. H. Eric Xu (CAS: Chinese Academy of Sciences)H-Index: 54
view all 22 authors...
Summary G protein-coupled receptors (GPCRs) mediate diverse signaling in part through interaction with arrestins, whose binding promotes receptor internalization and signaling through G protein-independent pathways. High-affinity arrestin binding requires receptor phosphorylation, often at the receptor's C-terminal tail. Here, we report an X-ray free electron laser (XFEL) crystal structure of the rhodopsin-arrestin complex, in which the phosphorylated C terminus of rhodopsin forms an extended in...
84 CitationsSource
#1Jun LuH-Index: 10
#2Noel ByrneH-Index: 7
Last. Stephen M. SoissonH-Index: 21
view all 34 authors...
Crystal structures of hGPR40, a target for treatment of type 2 diabetes, bound to a partial and an allosteric agonist explain the binding cooperativity between these ligands and present new opportunities for structure-guided drug design.
32 CitationsSource
#1Yingli Ma (Amgen)H-Index: 1
#2Yang Yue (ShanghaiTech University)H-Index: 1
Last. Fei Xu (ShanghaiTech University)H-Index: 12
view all 20 authors...
Summary Apelin receptor (APJR) is a key regulator of human cardiovascular function and is activated by two different endogenous peptide ligands, apelin and Elabela, each with different isoforms diversified by length and amino acid sequence. Here we report the 2.6-A resolution crystal structure of human APJR in complex with a designed 17-amino-acid apelin mimetic peptide agonist. The structure reveals that the peptide agonist adopts a lactam constrained curved two-site ligand binding mode. Combin...
28 CitationsSource
#1Haitao Zhang (SC: University of Southern California)H-Index: 14
#2Gye Won Han (SC: University of Southern California)H-Index: 42
Last. Vadim Cherezov (SC: University of Southern California)H-Index: 61
view all 26 authors...
Crystal structures of two complexes of the angiotensin II receptor AT2R with distinct tightly bound ligands reveal an active-like state of the receptor, in which helix VIII adopts a non-canonical position that blocks binding of G proteins and β-arrestins.
65 CitationsSource
#1Manoj K. PandeyH-Index: 46
#2Thomas A. BurrowH-Index: 16
Last. Gregory A. GrabowskiH-Index: 40
view all 12 authors...
Complement-activating glycosylceramide-specific autoantibodies drive a self-propagating cycle of glycosylceramide accumulation and inflammation in Gaucher disease.
33 CitationsSource
#1Pirow BekkerH-Index: 14
#2Daniel J. DairaghiH-Index: 23
Last. Thomas J. SchallH-Index: 60
view all 19 authors...
The complement 5a receptor has been an attractive therapeutic target for many autoimmune and inflammatory disorders. However, development of a selective and potent C5aR antagonist has been challenging. Here we describe the characterization of CCX168 (avacopan), an orally administered selective and potent C5aR inhibitor. CCX168 blocked the C5a binding, C5a-mediated migration, calcium mobilization, and CD11b upregulation in U937 cells as well as in freshly isolated human neutrophils. CCX168 retain...
21 CitationsSource
#1Andreza Urba de Quadros (USP: University of São Paulo)H-Index: 4
#2Thiago Mattar Cunha (USP: University of São Paulo)H-Index: 7
Pain is a distressing sensation, resulting from real or potential tissue damage. It is crucial to protect our body, but it can be so intense that it requires treatment. Furthermore, in some circumstances, pain can become persistent/chronic, such as that triggered by inflammatory disease or neuropathy. Treatments for pain are still a clinical challenge. An advance in the knowledge of the neurobiological mechanisms involved in the genesis of acute and chronic pain might be the fundamental approach...
6 CitationsSource
Cited By13
#1Xiangyu Liu (THU: Tsinghua University)H-Index: 4
#2Jonas Kaindl (FAU: University of Erlangen-Nuremberg)H-Index: 4
Last. R. Matt (Stanford University)H-Index: 2
view all 16 authors...
Most drugs acting on G-protein-coupled receptors target the orthosteric binding pocket where the native hormone or neurotransmitter binds. There is much interest in finding allosteric ligands for these targets because they modulate physiologic signaling and promise to be more selective than orthosteric ligands. Here we describe a newly developed allosteric modulator of the β2-adrenergic receptor (β2AR), AS408, that binds to the membrane-facing surface of transmembrane segments 3 and 5, as reveal...
#1David J. Brayden (UCD: University College Dublin)H-Index: 37
#2T.A. Hill (UQ: University of Queensland)
Last. Randall J. Mrsny (University of Bath)H-Index: 36
view all 5 authors...
Abstract In its 33 years, ADDR has published regularly on the potential of oral delivery of biologics especially peptides and proteins. In the intervening period, analysis of the preclinical and clinical trial failures of many purported platform technologies has led to reflection on the true status of the field and reigning in of expectations. Oral formulations of semaglutide, octreotide, and salmon calcitonin have completed Phase III trials, with oral semaglutide being approved by the FDA in 20...
#1Shubhi Pandey (IITK: Indian Institute of Technology Kanpur)H-Index: 4
#2Jagannath Maharana (IITK: Indian Institute of Technology Kanpur)H-Index: 1
Last. Arun K. Shukla (IITK: Indian Institute of Technology Kanpur)H-Index: 26
view all 5 authors...
Complement factor C5a is an integral constituent of the complement cascade critically involved in the innate immune response, and it exerts its functions via two distinct receptors, C5aR1 and C5aR2. While C5aR1 is a prototypical G-protein-coupled receptor (GPCR), C5aR2 lacks functional coupling to heterotrimeric G proteins, although both receptors efficiently recruit β arrestins (βarrs). Here, we discuss the recent studies providing direct structural details of ligand–receptor interactions, and ...
#1Andra-Cristina Dumitru (UCL: Université catholique de Louvain)H-Index: 3
#2R. N. V. Krishna Deepak (Agency for Science, Technology and Research)H-Index: 1
Last. David Alsteens (UCL: Université catholique de Louvain)H-Index: 32
view all 7 authors...
A current challenge in the field of life sciences is to decipher, in their native environment, the functional activation of cell surface receptors upon binding of complex ligands. Lack of suitable nanoscopic methods has hampered our ability to meet this challenge in an experimental manner. Here, we use for the first time the interplay between atomic force microscopy, steered molecular dynamics and functional assays to elucidate the complex ligand-binding mechanism of C5a with the human G protein...
#1Aleksandra Elzbieta Badaczewska-Dawid (Iowa State University)H-Index: 2
#1Aleksandra E. Badaczewska-Dawid (PAN: Polish Academy of Sciences)H-Index: 1
Last. Michal Kolinski (PAN: Polish Academy of Sciences)H-Index: 13
view all 3 authors...
The structural description of peptide ligands bound to G protein-coupled receptors (GPCRs) is important for the discovery of new drugs and deeper understanding of the molecular mechanisms of life. Here we describe a three-stage protocol for the molecular docking of peptides to GPCRs using a set of different programs: (1) CABS-dock for docking fully flexible peptides; (2) PD2 method for the reconstruction of atomistic structures from C-alpha traces provided by CABS-dock and (3) Rosetta FlexPepDoc...
Wellcome Trust [WT107715/Z/15/Z], Cambridge Biomedical Research Centre Biomedical Resources Grant
1 CitationsSource
#1Abdul Rehman (RU: Rutgers University)
#2Noor Ul-Ain Baloch (RU: Rutgers University)H-Index: 3
Last. György Haskó (Columbia University)H-Index: 20
view all 5 authors...
Abstract The Third International Consensus Definitions (Sepsis-3) define sepsis as life-threatening multi-organ dysfunction caused by a dysregulated host response to infection. Sepsis can progress to septic shock—an even more lethal condition associated with profound circulatory, cellular and metabolic abnormalities. Septic shock remains a leading cause of death in intensive care units and carries a mortality of almost 25%. Despite significant advances in our understanding of the pathobiology of...
#1Chao Zuo (THU: Tsinghua University)H-Index: 5
#2Baochang Zhang (THU: Tsinghua University)
Last. Ge-Min Fang (Anda: Anhui University)H-Index: 1
view all 6 authors...
Abstract The deletion of the C-terminal arginine of the anaphylatoxin protein C5a reduces it receptor binding affinity. Understanding how C-terminal arginine affects the structure and bioactivity of C5a is important for the development of C5a C-terminal mimics as drug candidates. Herein, we report the total chemical synthesis of rat C5a and its d -enantiomer with its C-terminal arginine deleted, namely l -rC5a-desArg and d -rC5a-desArg. The structure of rC5a-desArg was then determined by racemic...
#1You-wen Zhuang (CAS: Chinese Academy of Sciences)H-Index: 1
#2Heng Liu (University of Pittsburgh)H-Index: 3
Last. Gongpu Zhao (Van Andel Institute)H-Index: 3
view all 16 authors...
Formylpeptide receptors (FPRs) as G protein-coupled receptors (GPCRs) can recognize formylpeptides derived from pathogens or host cells to function in host defense and cell clearance. In addition, FPRs, especially FPR2, can also recognize other ligands with a large chemical diversity generated at different stages of inflammation to either promote or resolve inflammation in order to maintain a balanced inflammatory response. The mechanism underlying promiscuous ligand recognition and activation o...
4 CitationsSource
#1Brian J. Bender (Vandy: Vanderbilt University)H-Index: 4
#1Brian Bender (UCSF: University of California, San Francisco)H-Index: 1
Last. Jens Meiler (Vandy: Vanderbilt University)H-Index: 50
view all 3 authors...
G-protein coupled receptors (GPCRs) represent a significant target class for pharmaceutical therapies. However, to date, only about 10% of druggable GPCRs have had their structures characterized at atomic resolution. Further, because of the flexibility of GPCRs, alternative conformations remain to be modeled, even after an experimental structure is available. Thus, computational modeling of GPCRs is a crucial component for understanding biological function and to aid development of new therapeut...
1 CitationsSource